View in EDS

Synergism between the tyrosine kinase inhibitor sunitinib and Anti-TNF antibody protects against lethal dengue infection.

Saved in:
Bibliographic Details
Title: Synergism between the tyrosine kinase inhibitor sunitinib and Anti-TNF antibody protects against lethal dengue infection.
Authors: Branche E; Division of Inflammation Biology, La Jolla Institute for Allergy & Immunology, La Jolla, CA, USA., Tang WW; Division of Inflammation Biology, La Jolla Institute for Allergy & Immunology, La Jolla, CA, USA., Viramontes KM; Division of Inflammation Biology, La Jolla Institute for Allergy & Immunology, La Jolla, CA, USA., Young MP; Division of Inflammation Biology, La Jolla Institute for Allergy & Immunology, La Jolla, CA, USA., Sheets N; Division of Inflammation Biology, La Jolla Institute for Allergy & Immunology, La Jolla, CA, USA., Joo Y; Division of Inflammation Biology, La Jolla Institute for Allergy & Immunology, La Jolla, CA, USA., Nguyen AT; Division of Inflammation Biology, La Jolla Institute for Allergy & Immunology, La Jolla, CA, USA., Shresta S; Division of Inflammation Biology, La Jolla Institute for Allergy & Immunology, La Jolla, CA, USA; Department of Medicine, School of Medicine, University of California, San Diego, La Jolla, CA, USA. Electronic address: sujan@lji.org.
Source: Antiviral research [Antiviral Res] 2018 Oct; Vol. 158, pp. 1-7. Date of Electronic Publication: 2018 Jul 30.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8109699 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-9096 (Electronic) Linking ISSN: 01663542 NLM ISO Abbreviation: Antiviral Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1872-9096
DOI:10.1016/j.antiviral.2018.07.022